statistiche ricercatore

Continente	#
AS - Asia	412
NA - Nord America	354
EU - Europa	303
SA - Sud America	26
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	12
Totale	1.129

Nazione	#
US - Stati Uniti d'America	337
IT - Italia	175
CN - Cina	101
SG - Singapore	95
VN - Vietnam	91
BD - Bangladesh	48
DE - Germania	26
HK - Hong Kong	26
NL - Olanda	25
BR - Brasile	16
JP - Giappone	13
IE - Irlanda	11
KR - Corea	10
CA - Canada	9
FI - Finlandia	9
GB - Regno Unito	9
IN - India	9
SE - Svezia	8
AR - Argentina	6
FR - Francia	6
CH - Svizzera	5
JO - Giordania	5
RU - Federazione Russa	5
CI - Costa d'Avorio	4
UA - Ucraina	4
BG - Bulgaria	3
GR - Grecia	3
MX - Messico	3
PH - Filippine	3
TW - Taiwan	3
AT - Austria	2
ES - Italia	2
HR - Croazia	2
ID - Indonesia	2
LT - Lituania	2
LV - Lettonia	2
NI - Nicaragua	2
PE - Perù	2
SC - Seychelles	2
TR - Turchia	2
ZA - Sudafrica	2
A2 - ???statistics.table.value.countryCode.A2???	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DM - Dominica	1
DZ - Algeria	1
HU - Ungheria	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
MD - Moldavia	1
NG - Nigeria	1
OM - Oman	1
PK - Pakistan	1
PL - Polonia	1
PY - Paraguay	1
SA - Arabia Saudita	1
SN - Senegal	1
SV - El Salvador	1
Totale	1.108

Nome	#
Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant	235
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort	175
Anti-LGI1 encephalitis following COVID-19 vaccination: a case series	139
Frontal encephalopathy related to hyperinflammation in COVID-19	108
Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort	101
Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study	85
Inflammatory optic neuropathy following SARS-CoV-2 mRNA vaccine: Description of two cases	80
Reply: Infections and Stiff-Person Spectrum Disorders	65
Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation	54
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis	36
Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study	28
Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke	23
Totale	1.129

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	18	0	0	0	1	2	3	1	0	0	4	1	6
2022/2023	91	3	2	1	7	5	6	4	9	23	6	12	13
2023/2024	84	3	9	17	8	3	20	0	5	6	6	1	6
2024/2025	221	9	16	20	13	23	14	12	19	6	27	21	41
2025/2026	622	55	48	44	40	52	17	43	9	103	55	53	103
2026/2027	81	40	41	0	0	0	0	0	0	0	0	0	0
Totale													1.129

CRIS Current Research Information System